UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1383-1389

2003

Volltextzugriff (PDF)

ASHP Guidelines on Preventing Medication Errors with Chemotherapy and Biotherapy

American journal of health-system pharmacy, 2015-04, Vol.72 (8), p.e6-e35

2015

Volltextzugriff (PDF)

Establishment of a research pharmacy to support Ebola clinical research in Liberia

Journal of the American Pharmacists Association, 2017-07, Vol.57 (4), p.542-546

2017

Volltextzugriff (PDF)

Adolescents and young adults with cancer : The scope of the problem and criticality of clinical trials

Cancer, 2006-10, Vol.107 (7), p.1645-1655

2006

Volltextzugriff (PDF)

Pharmacist readiness roles for emergency preparedness

American journal of health-system pharmacy, 2011-04, Vol.68 (7), p.620-623

2011

Volltextzugriff (PDF)

National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation

Cancer, 2005-05, Vol.103 (9), p.1891-1897

2005

Volltextzugriff (PDF)

The challenges of clinical trials for adolescents and young adults with cancer

Pediatric blood & cancer, 2008-05, Vol.50 (S5), p.1101-1104

2008

Volltextzugriff (PDF)

Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Translational behavioral medicine, 2011-03, Vol.1 (1), p.110-122

2011

Volltextzugriff (PDF)

Dosing cards for treatment of children exposed to weapons of mass destruction

American journal of health-system pharmacy, 2006-05, Vol.63 (10), p.944-949

2006

Volltextzugriff (PDF)

NCI’s national treatment trial networks: Experience and adaptations during COVID-19

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1562-1562

2021

Volltextzugriff (PDF)

Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN)

Clinical cancer research, 2019-12, Vol.25 (23), p.6925-6931

2019

Volltextzugriff (PDF)

Transparency around disapproval reasons of early-phase trial proposals submitted to the National Cancer Institute (NCI)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6585-6585

2017

Volltextzugriff (PDF)

Readability and compliance of NCI's informed consent documents (ICDs) with its revised ICD template

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18162-e18162

2016

Volltextzugriff (PDF)

Leading the way: The National Cancer Institute’s (NCI) single IRB for multi-site research

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e18259-e18259

2017

Volltextzugriff (PDF)

National coverage analyses for NCI clinical trials: A pilot project to reduce participation barriers

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6542-6542

2017

Volltextzugriff (PDF)

2001 anthrax crisis in Washington, D.C.: pharmacists' role in screening patients and selecting prophylaxis

American journal of health-system pharmacy, 2002-06, Vol.59 (12), p.1193-1199

2002

Volltextzugriff (PDF)

2001 anthrax crisis in Washington, D.C.: clinic for persons exposed to contaminated mail

American journal of health-system pharmacy, 2002-06, Vol.59 (12), p.1189-1192

2002

Volltextzugriff (PDF)

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3007-3015

1998

Volltextzugriff (PDF)

Adolescents and young adults with cancer

Cancer, 2006-10, Vol.107 (S7), p.1645-1655

2006

Volltextzugriff (PDF)

ASHP guidelines on preventing medication errors with antineoplastic agents

American journal of health-system pharmacy, 2002-09, Vol.59 (17), p.1648-1668

2002

Volltextzugriff (PDF)

Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction

Journal of clinical oncology, 1997-05, Vol.15 (5), p.2125-2134

1997

Volltextzugriff (PDF)

National survival trends of young adults with sarcoma

Cancer, 2005-05, Vol.103 (9), p.1891-1897

2005

Volltextzugriff (PDF)

Therapeutic selection during an emergency response

American journal of health-system pharmacy, 1999-02, Vol.56 (3), p.236-240

1999

Volltextzugriff (PDF)

2001 anthrax crisis in Washington, D.C.: Pharmacists'role in screening patients and selecting prophylaxis

American journal of health-system pharmacy, 2002, Vol.59 (12), p.1193-1199

2002

Volltextzugriff (PDF)

Standardizing the expression and nomenclature of cancer treatment regimens

American journal of health-system pharmacy, 1998-01, Vol.55 (2), p.137-144

1998

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Humans
(17)
Life Sciences & Biomedicine
(17)
Biological And Medical Sciences
(9)
Pharmacology & Pharmacy
(9)
Medical Sciences
(8)
Oncology
(7)
Adult
(6)
Female
(6)
Male
(6)
Pharmacology. Drug Treatments
(6)
Adolescent
(5)
Antineoplastic Agents
(5)
Pharmacists
(5)
United States
(5)
Adolescents
(4)
Antineoplastic Agents - Therapeutic Use
(4)
Chemotherapy
(4)
Clinical Trials
(4)
Middle Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials

ASHP Guidelines on Preventing Medication Errors with Chemotherapy and Biotherapy

Establishment of a research pharmacy to support Ebola clinical research in Liberia

Adolescents and young adults with cancer : The scope of the problem and criticality of clinical trials

Pharmacist readiness roles for emergency preparedness

National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation

The challenges of clinical trials for adolescents and young adults with cancer

Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Dosing cards for treatment of children exposed to weapons of mass destruction

NCI’s national treatment trial networks: Experience and adaptations during COVID-19

Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN)

Transparency around disapproval reasons of early-phase trial proposals submitted to the National Cancer Institute (NCI)

Readability and compliance of NCI's informed consent documents (ICDs) with its revised ICD template

Leading the way: The National Cancer Institute’s (NCI) single IRB for multi-site research

National coverage analyses for NCI clinical trials: A pilot project to reduce participation barriers

2001 anthrax crisis in Washington, D.C.: pharmacists' role in screening patients and selecting prophylaxis

2001 anthrax crisis in Washington, D.C.: clinic for persons exposed to contaminated mail

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients

Adolescents and young adults with cancer

ASHP guidelines on preventing medication errors with antineoplastic agents

Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction

National survival trends of young adults with sarcoma

Therapeutic selection during an emergency response

2001 anthrax crisis in Washington, D.C.: Pharmacists'role in screening patients and selecting prophylaxis

Standardizing the expression and nomenclature of cancer treatment regimens

Aktive Filter

Suchergebnisse filtern